NEW YORK (Reuters Health) – The presence of deep venous thrombosis (DVT) in patients with pulmonary embolism is associated with an increased risk of death, according to a…
NEW YORK (Reuters Health) – A single negative whole-leg compression ultrasound (CUS) can effectively rule out deep vein thrombosis (DVT) in many patients, according to a meta-analysis in…
NEW YORK (Reuters Health) – Whether clopidogrel is abruptly stopped or slowly tapered, there is no evidence of a rebound in platelet activity, German researchers report. They point…
NEW YORK (Reuters Health) – Performing coronary artery bypass graft (CABG) surgery in high-risk patients without placing them on cardiopulmonary bypass does not increase their risk of short-term…
NEW YORK (Reuters Health) – Starting heparin in the emergency department (ED) rather than after admission may improve the survival of patients with acute pulmonary embolism (PE), according…
NEW YORK (Reuters Health) – The pure class III anti-arrhythmic drug nifekalant is more effective than lidocaine for terminating refractory ventricular fibrillation (VF) or ventricular tachycardia (VT), Japanese…
NEW YORK (Reuters Health) – Treating septic shock with steroids produces hyperglycemia, but patients are no better off with intensive insulin therapy than with conventional glucose control, according…
NEW YORK (Reuters Health) – In patients with middle cerebral artery occlusion, an alteplase dosage of 0.6 mg/kg IV is comparable to a 0.9 mg/kg dosage for achieving…
NEW YORK (Reuters Health) – Operative mortality after coronary artery bypass grafting (CABG) is higher in women, even after adjustment for preoperative risk factors, according to a study…
NEW YORK (Reuters Health) – When paroxysmal atrial fibrillation has not responded to at least one antiarrhythmic agent, radiofrequency catheter ablation is more effective at preventing further episodes…